Furthermore, systemic symptoms and signs-particularly arthralgia, arthritis, dry eyes, or nephropathy that frequently accompany idiopathic SCLE-are generally absent in PD-1/PD-L1 inhibitor-induced cases (39). Here, PDCD1 is linked to kidney disorder.